Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection

Adamo, 2010, Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia, Mol. Cell, 39, 25, 10.1016/j.molcel.2010.06.026 Bakkenist, 2003, DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation, Nature, 421, 499, 10.1038/nature01368 Balmus, 2019, ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks, Nat. Commun., 10, 87, 10.1038/s41467-018-07729-2 Bassi, 2013, Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress, Science, 341, 395, 10.1126/science.1236188 Batey, 2013, Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer, Mol. Cancer Ther., 12, 959, 10.1158/1535-7163.MCT-12-0707 Benitez, 2018, FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange, Mol. Cell, 71, 621, 10.1016/j.molcel.2018.06.030 Bryant, 2005, Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase, Nature, 434, 913, 10.1038/nature03443 Bunting, 2010, Dangerous liaisons: Fanconi anemia and toxic nonhomologous end joining in DNA crosslink repair, Mol. Cell, 39, 164, 10.1016/j.molcel.2010.07.016 2015, Pharmacogenomic agreement between two cancer cell line data sets, Nature, 528, 84, 10.1038/nature15736 Ceccaldi, 2015, Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair, Nature, 518, 258, 10.1038/nature14184 Ceccaldi, 2016, Repair Pathway Choices and Consequences at the Double-Strand Break, Trends Cell Biol., 26, 52, 10.1016/j.tcb.2015.07.009 Ceccaldi, 2016, The Fanconi anaemia pathway: new players and new functions, Nat. Rev. Mol. Cell Biol., 17, 337, 10.1038/nrm.2016.48 Chanut, 2016, Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks, Nat. Commun., 7, 12889, 10.1038/ncomms12889 Doench, 2016, Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat. Biotechnol., 34, 184, 10.1038/nbt.3437 Duquette, 2012, CtIP is required to initiate replication-dependent interstrand crosslink repair, PLoS Genet., 8, e1003050, 10.1371/journal.pgen.1003050 Eccles, 2018, Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks, DNA Repair (Amst.), 64, 1, 10.1016/j.dnarep.2018.02.003 Farmer, 2005, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, 434, 917, 10.1038/nature03445 Gupta, 2009, Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair, Cell Cycle, 8, 2198, 10.4161/cc.8.14.8947 Harris, 2011, BRCA1 A‐complex fine tunes repair functions of BRCA1, Aging (Albany N.Y.), 3, 461 Hickson, 2004, Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM, Cancer Res., 64, 9152, 10.1158/0008-5472.CAN-04-2727 Higgins, 2018, Beyond PARP-POLθ as an anticancer target, Science, 359, 1217, 10.1126/science.aar5149 Howard, 2015, DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining, PLoS Genet., 11, e1004943, 10.1371/journal.pgen.1004943 Huertas, 2018, Single Molecule Analysis of Resection Tracks, Methods Mol. Biol., 1672, 147, 10.1007/978-1-4939-7306-4_12 Kennedy, 2007, Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated, J. Clin. Invest., 117, 1440, 10.1172/JCI31245 Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 Lord, 2016, BRCAness revisited, Nat. Rev. Cancer, 16, 110, 10.1038/nrc.2015.21 Maruyama, 2015, Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining, Nat. Biotechnol., 33, 538, 10.1038/nbt.3190 Mateos-Gomez, 2015, Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination, Nature, 518, 254, 10.1038/nature14157 McCabe, 2015, Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM, Cancer Res., 75, 2159, 10.1158/0008-5472.CAN-14-3502 Meyers, 2017, Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells, Nat. Genet., 49, 1779, 10.1038/ng.3984 Mirman, 2018, 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in, Nature, 560, 112, 10.1038/s41586-018-0324-7 Mondal, 2019, A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers, Nat. Commun., 10, 1686, 10.1038/s41467-019-09659-z Murina, 2014, FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks, Cell Rep., 7, 1030, 10.1016/j.celrep.2014.03.069 Nakanishi, 2005, Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair, Proc. Natl. Acad. Sci. USA, 102, 1110, 10.1073/pnas.0407796102 Newell, 2004, Interstrand crosslink-induced radials form between non-homologous chromosomes, but are absent in sex chromosomes, DNA Repair (Amst.), 3, 535, 10.1016/j.dnarep.2004.01.011 Pace, 2010, Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway, Science, 329, 219, 10.1126/science.1192277 Pettitt, 2018, Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance, Nat. Commun., 9, 1849, 10.1038/s41467-018-03917-2 Rodríguez, 2017, Fanconi anemia pathway, Curr. Biol., 27, R986, 10.1016/j.cub.2017.07.043 Shalem, 2014, Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, 343, 84, 10.1126/science.1247005 Shen, 2007, Essential role for nuclear PTEN in maintaining chromosomal integrity, Cell, 128, 157, 10.1016/j.cell.2006.11.042 Shiloh, 2013, The ATM protein kinase: regulating the cellular response to genotoxic stress, and more, Nat. Rev. Mol. Cell Biol., 14, 197, 10.1038/nrm3546 Sobhian, 2007, RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites, Science, 316, 1198, 10.1126/science.1139516 Song, 2010, Rad18-mediated translesion synthesis of bulky DNA adducts is coupled to activation of the Fanconi anemia DNA repair pathway, J. Biol. Chem., 285, 31525, 10.1074/jbc.M110.138206 Stoepker, 2015, Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer, Cancer Res., 75, 3543, 10.1158/0008-5472.CAN-15-0528 Swift, 1999, Link between breast cancer and ATM gene is strong, BMJ, 318, 400, 10.1136/bmj.318.7180.400 Symington, 2016, Mechanism and regulation of DNA end resection in eukaryotes, Crit. Rev. Biochem. Mol. Biol., 51, 195, 10.3109/10409238.2016.1172552 Taniguchi, 2002, Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways, Cell, 109, 459, 10.1016/S0092-8674(02)00747-X Taniguchi, 2003, Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors, Nat. Med., 9, 568, 10.1038/nm852 Terret, 2009, Cohesin acetylation speeds the replication fork, Nature, 462, 231, 10.1038/nature08550 Tittel-Elmer, 2012, Cohesin association to replication sites depends on rad50 and promotes fork restart, Mol. Cell, 48, 98, 10.1016/j.molcel.2012.07.004 Unno, 2014, FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair, Cell Rep., 7, 1039, 10.1016/j.celrep.2014.04.005 van der Heijden, 2005, In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor, Clin. Cancer Res., 11, 7508, 10.1158/1078-0432.CCR-05-1048 Wang, 2013, The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair, PLoS Genet., 9, e1003277, 10.1371/journal.pgen.1003277 Watrin, 2009, The cohesin complex is required for the DNA damage-induced G2/M checkpoint in mammalian cells, EMBO J., 28, 2625, 10.1038/emboj.2009.202 Williams, 2011, The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI, Blood, 117, 5078, 10.1182/blood-2010-10-311761 Wu, 2012, The Smc complexes in DNA damage response, Cell Biosci., 2, 5, 10.1186/2045-3701-2-5 Yang, 2013, Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells, Nucleic Acids Res., 41, D955, 10.1093/nar/gks1111 Yeo, 2014, CtIP mediates replication fork recovery in a FANCD2-regulated manner, Hum. Mol. Genet., 23, 3695, 10.1093/hmg/ddu078 Zehir, 2017, Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients, Nat. Med., 23, 703, 10.1038/nm.4333 Zhou, 2014, Quantitation of DNA double-strand break resection intermediates in human cells, Nucleic Acids Res., 42, e19, 10.1093/nar/gkt1309 Zimmermann, 2018, Abstract 338: A new investigational ATM Inhibitor, M3541, synergistically potentiates fractionated radiotherapy and chemotherapy in cancer cells and animal models, Proceedings of the AACR Annual Meeting 2018, 78, 338